Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays
about
Spectrum of false positivity for the fourth generation human immunodeficiency virus diagnostic tests.Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon.Rapid detection and differentiation of antibodies to HIV-1 and HIV-2 using multivalent antigens and magnetic immunochromatography testing.Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibodyFalse-positive rate of a "fourth-generation" HIV antigen/antibody combination assay in an area of low HIV prevalence.Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificityCandida albicans keratitis in an immunocompromised patientGeneration of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests.Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra.The cost-effectiveness of expanded testing for primary HIV infection.Detecting viruses by using salivary diagnostics.Subtype B human immunodeficiency virus (HIV) type 1 mutant that escapes detection in a fourth-generation immunoassay for HIV infection.Performance of the Liaison XL Murex HIV Ab/Ag test on clinical samples representing current epidemic HIV variants.Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen.Evaluation of HIV antigen/antibody combination ELISAs for diagnosis of HIV infection in Dar Es Salaam, Tanzania.Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.Point-of-care testing for HIV: HIV counselling and testing.Stochastic models to demonstrate the effect of motivated testing on HIV incidence estimates using the serological testing algorithm for recent HIV seroconversion (STARHS)Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.Reduction of the HIV seroconversion window period and false positive rate by using ADVIA Centaur HIV antigen/antibody combo assay.Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay.Clinical evaluation of BioPlex 2200 HIV Ag-Ab, an automated screening method providing discrete detection of HIV-1 p24 antigen, HIV-1 antibody, and HIV-2 antibody.New automated chemiluminescence immunoassay for simultaneous but separate detection of human immunodeficiency virus antigens and antibodies.Misdiagnosis of HIV infection during a South African community-based survey: implications for rapid HIV testing.Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection.Novel Time-Resolved Fluorescence Europium Nanoparticle Immunoassay for Detection of Human Immunodeficiency Virus-1 Group O Viruses Using Microplate and Microchip Platforms.Contribution of combined detection assays of p24 antigen and anti-human immunodeficiency virus (HIV) antibodies in diagnosis of primary HIV infection by routine testing.Human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection.Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting.
P2860
Q30277806-29A5D510-1335-44A1-BB61-4F424EB0D40FQ33515282-02259CEC-77CF-4B5A-8CCC-98B7DED1DA69Q33909167-62CECA6F-99DA-4878-8C43-1F270E591666Q33972881-E7C1EFBB-3E34-4995-B5F3-2A5C2FAC4A06Q34189925-87D66E86-6881-4A9A-8C96-BD927DC9819AQ34195573-66E98061-9BAD-4669-BEC1-61018F3A11ACQ34245270-772D44B5-B516-436E-B2A1-487BC0C1394AQ34400923-8A023517-BC39-486E-85BA-4D92CA64EDC3Q34453624-746A7F7F-7B33-439C-B204-92F452092980Q34629478-ABD525BC-5192-4A7C-B5FF-9908ABC8160CQ34675315-2CF9912D-6A0F-4913-B1FF-DC22B02894F2Q34783131-978FD1E4-AF0A-419C-ADAF-B517F200E80DQ35035727-0A7766E6-3572-49CE-8DCB-A08FBBC28423Q35551617-4FDD2EAC-EE3F-4933-96E6-22038F5DB6C0Q35748472-5A996C5E-BFA7-4BB2-888A-C67DEAC25DACQ36099119-0DCDE639-C6F0-4E01-B95A-7779CC133B25Q36170504-47634384-2948-4E2A-BB72-0AECF3977777Q36182422-F3294F61-922D-4EA5-B213-7DC5D63524BDQ36780418-C8E25010-1CFF-4518-B64F-A2491C228BA5Q37284972-7F00F9FD-00DC-414B-8161-CAC15ABCC6CDQ37347026-F9270657-A13E-48A2-9A31-E263801CC1B7Q37546640-CA2A6A57-3070-4631-B833-A6030B8F085AQ38857345-BCEDB532-7F88-4EF0-B784-727E3BCA2A9AQ39150244-30F06BA0-534A-46EE-BE60-056B1696CEACQ39466015-BD940811-6366-4E81-8534-D890A9172CFCQ39919619-A7DED56D-2412-4DD6-A558-465AF679BB4AQ42726649-EE25C354-5DB0-4093-9147-942B2109784BQ42829093-6756A698-C537-476F-AE8A-0977507807C2Q43071702-BE7FF15A-26E1-4D80-9A97-4E4DD2B6EE13
P2860
Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Reduction of diagnostic window ...... iciency virus screening assays
@ast
Reduction of diagnostic window ...... iciency virus screening assays
@en
type
label
Reduction of diagnostic window ...... iciency virus screening assays
@ast
Reduction of diagnostic window ...... iciency virus screening assays
@en
prefLabel
Reduction of diagnostic window ...... iciency virus screening assays
@ast
Reduction of diagnostic window ...... iciency virus screening assays
@en
P2093
P2860
P1476
Reduction of diagnostic window ...... iciency virus screening assays
@en
P2093
P2860
P304
P407
P577
1998-08-01T00:00:00Z